Back to results
US 2024/0181012 A1Published application
Method for ameliorating autism symptoms by pharmacological activation of the neurotensin receptor 1 (ntsr1)
AssigneeNew York Institute of Technology
InventorGonzalo Hugo OTAZU ALDANA
Life of this patent
Estimating the term…
Abstract
Methods and formulations for treating autism with neurotensin R1 agonists without causing significant lethargy in a subject.
Claims21
A formulation of a neurotensin R1 agonist for treating a symptom of an autism spectrum disorder without causing lethargy in a subject, comprising:
- a) an amount of a neurotensin R1 agonist effective to treat a symptom of an autism;
- and
- b) an amount of a polyethylene glycol polymer.
A method of treating a symptom of an autism spectrum disorder in a subject comprising administering to the subject an amount of a neurotensin R1 agonist effective to treat a symptom of an autism spectrum disorder.
Dependencies are inferred from the claim text.